Breast Cancer Research

Table 2 Survival analysis according to the Kaplan-Meier method

From: Presence of circulating Her2-reactive CD8 + T-cells is associated with lower frequencies of myeloid-derived suppressor cells and regulatory T cells, and better survival in older breast cancer patients

			Overall survival rate
Factor	N ¹	% dead (5 years)	%	95% CI	P
Metastasis					0.03
No	33	28	72	0.01-0.8
Yes	6	50	40	1.1-65.6
Estrogen receptor					0.3
No	9	44	55	0.5-8.1
Yes	30	23	75	0.1-1.9
Progesterone receptor					0.7
No	12	25	72	0.2-2.9
Yes	27	29	69	0.3-4.3
Her2 status					0.3
Neg	34	26	72	0.05-2.8
Pos	4	50	50	0.3-17.9
Chemotherapy					0.2
Yes	3	0	100	0.04-2.3
No	37	12	65	0.4-21.07
Radiotherapy					0.003
Yes	27	19	81	0.03-0.5
No	13	54	37	1.9-28.6
Hormonal therapy					0.3
Yes	30	27	72	0.1-1.9
No	10	40	53	0.5-8.2
CD8 response to Her2					0.03
Yes	18	17	82	0.09-0.9
No	20	45	52	1.07-10.4
MDSC-1					0.7
<median	18	28	70	0.2-2.6
≥median	19	32	66	0.3-4.01
MDSC-2					0.8
<median	18	33	66	0.3-3.7
≥median	19	26	70	0.2-2.8

Results of survival analysis according to Kaplan-Meier method and P values from Mantex-Cox (log rank) test.

Back to article page

ISSN: 1465-542X

Contact us

Submission enquiries: journalsubmissions@springernature.com